OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis

Introduction The power of ‘real world’ data to improve our understanding of the clinical aspects of multiple sclerosis (MS) is starting to be realised. Disease modifying therapy (DMT) use across the UK is driven by national prescribing guidelines. As such, the UK provides an ideal country in which t...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ana Cavey, Ruth Dobson, Camilla Blain, Richard Nicholas, Jeremy Hobart, David Rog, Monica Marta, Cheryl Hemingway, Nikos Evangelou, Matthew Craner, Paul M Matthews, Neil Scolding, Helen L Ford, Stewart Webb, Ed Waddingham, Aleisha Miller, Carolyn Anne Young
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMJ Publishing Group 2021-11-01
Colección:	BMJ Open
Acceso en línea:	https://bmjopen.bmj.com/content/11/11/e050176.full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!